Brief: Bioceltix EGM Votes On Increase Of Share Capital Via Issue Of K Series Shares
March 14 (Reuters) - Bioceltix SA BCXP.WA :
* REPORTED ON MONDAY THAT EXTRAORDINARY GENERAL MEETING
VOTED ON
INCREASE OF SHARE CAPITAL UP TO 397,947 ZLOTYS VIA ISSUE OF UP
TO 400,000 K SERIES SHARES IN A PRIVATE SUBSCRIPTION
* K SERIES SHARES TO BE ISSUED WITHOUT PRE-EMPTIVE RIGHTS
FOR
COMPANY'S SHAREHOLDERS
Source text for Eikon: urn:newsml:reuters.com:*:nEM1Wfc7ka
Further company coverage: BCXP.WA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Bioceltix SA
See all newsBrief: Bioceltix Signs 2 Mln Zlotys Net Deal With Intero For Construction Works
Brief: Bioceltix Receives Permit For Biological Veterinary Drugs Facility
Brief: Bioceltix Veterinary Biological Drug Project InnoBioVet Recommended For 15.1 Million Zloty Subsidy
Brief: Bioceltix Signs Advisory Agreement For FDA Regulatory Support
Brief: Bioceltix Gets GMP Certificate For Wroclaw Veterinary Medicine Facility